Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_983fa366d54b080542742d72951c002c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5306 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5764 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-563 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-576 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-563 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576 |
filingDate |
2018-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f94f1484ec9787b0447c912224d60a6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44a8080c4b9c5e5736728ca6879b5181 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec71531507576768af23fb333b3f5c16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e4fe85e5bccb7b2393b046701c5d95a |
publicationDate |
2022-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11454632-B2 |
titleOfInvention |
Assay method and assay kit for hepatitis B virus S antigen |
abstract |
Disclosed is a highly sensitive assay method and assay kit for HBsAg, which do not require treatment with a strong acid or alkali in the sample pretreatment, and which is less susceptible to influences by the autoantibodies. The assay method for hepatitis B virus s antigen in a sample separated from a living body includes: a pretreatment step of mixing a sample with a pretreatment reagent containing a reducing agent, to reduce hepatitis B virus s antigen; and an immunoassay step of subjecting the pretreated sample to an immunoassay of hepatitis B virus s antigen using at least one antibody or antigen-binding fragment thereof capable of antigen-antibody reaction with a reduced peptide composed of the amino acids at positions 98 to 179 of hepatitis B virus s antigen. |
priorityDate |
2017-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |